• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Contacts between membrane proximal regions of the PDGF receptor ectodomain are required for receptor activation but not for receptor dimerization.血小板衍生生长因子受体胞外域膜近端区域之间的接触是受体激活所必需的,但不是受体二聚化所必需的。
Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7681-6. doi: 10.1073/pnas.0802896105. Epub 2008 May 27.
2
Transactivation of PDGFRbeta by dopamine D4 receptor does not require PDGFRbeta dimerization.多巴胺 D4 受体对 PDGFRβ的转激活作用不需要 PDGFRβ二聚化。
Mol Brain. 2010 Jul 26;3:22. doi: 10.1186/1756-6606-3-22.
3
Mutation of tyrosine residue 857 in the PDGF beta-receptor affects cell proliferation but not migration.PDGFβ 受体酪氨酸残基 857 的突变影响细胞增殖但不影响迁移。
Cell Signal. 2010 Sep;22(9):1363-8. doi: 10.1016/j.cellsig.2010.05.004. Epub 2010 May 18.
4
The platelet-derived growth factor receptor-beta phosphorylates and activates G protein-coupled receptor kinase-2. A mechanism for feedback inhibition.血小板衍生生长因子受体-β使G蛋白偶联受体激酶-2磷酸化并激活。一种反馈抑制机制。
J Biol Chem. 2005 Sep 2;280(35):31027-35. doi: 10.1074/jbc.M501473200. Epub 2005 Jul 1.
5
Structures of a platelet-derived growth factor/propeptide complex and a platelet-derived growth factor/receptor complex.血小板衍生生长因子/前肽复合物和血小板衍生生长因子/受体复合物的结构。
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11307-12. doi: 10.1073/pnas.1000806107. Epub 2010 Jun 2.
6
Low density lipoprotein receptor-related protein 1 (LRP1) controls endocytosis and c-CBL-mediated ubiquitination of the platelet-derived growth factor receptor beta (PDGFR beta).低密度脂蛋白受体相关蛋白1(LRP1)控制血小板衍生生长因子受体β(PDGFRβ)的内吞作用和c-CBL介导的泛素化。
J Biol Chem. 2005 May 6;280(18):18504-10. doi: 10.1074/jbc.M410265200. Epub 2005 Mar 7.
7
Domain-dependent modulation of PDGFRbeta by ganglioside GM1.神经节苷脂GM1对血小板衍生生长因子受体β(PDGFRβ)的结构域依赖性调节
J Mol Neurosci. 2003 Apr;20(2):103-14. doi: 10.1385/JMN:20:2:103.
8
An antibody reactive with domain 4 of the platelet-derived growth factor beta receptor allows BB binding while inhibiting proliferation by impairing receptor dimerization.一种与血小板衍生生长因子β受体结构域4发生反应的抗体可实现BB结合,同时通过损害受体二聚化来抑制增殖。
J Biol Chem. 1997 Jul 11;272(28):17400-4. doi: 10.1074/jbc.272.28.17400.
9
Dimerization drives PDGF receptor endocytosis through a C-terminal hydrophobic motif shared by EGF receptor.二聚化通过 EGF 受体共享的 C 端疏水性基序驱动 PDGF 受体内吞。
Exp Cell Res. 2010 Aug 15;316(14):2237-50. doi: 10.1016/j.yexcr.2010.05.012. Epub 2010 May 16.
10
PKG II inhibits PDGF-BB triggered biological activities by phosphorylating PDGFRβ in gastric cancer cells.PKG II 通过在胃癌细胞中磷酸化 PDGFRβ 来抑制 PDGF-BB 触发的生物学活性。
Cell Biol Int. 2018 Sep;42(10):1358-1369. doi: 10.1002/cbin.11020. Epub 2018 Jul 4.

引用本文的文献

1
Multiple allostery in the regulation of PDGFR beta kinase activities.血小板衍生生长因子受体β激酶活性调节中的多重变构现象
Acta Biochim Biophys Sin (Shanghai). 2024 Nov 29;57(3):344-355. doi: 10.3724/abbs.2024205.
2
PDGFRA K385 mutants in myxoid glioneuronal tumors promote receptor dimerization and oncogenic signaling.黏液样-神经胶质肿瘤中的 PDGFRA K385 突变体促进受体二聚化和致癌信号。
Sci Rep. 2024 Mar 26;14(1):7204. doi: 10.1038/s41598-024-57859-5.
3
Cryo-EM analyses of KIT and oncogenic mutants reveal structural oncogenic plasticity and a target for therapeutic intervention.冷冻电镜分析 KIT 和致癌突变体揭示了结构致癌可塑性和治疗干预的靶点。
Proc Natl Acad Sci U S A. 2023 Mar 28;120(13):e2300054120. doi: 10.1073/pnas.2300054120. Epub 2023 Mar 21.
4
Glycan Modulation of Insulin-like Growth Factor-1 Receptor.糖基化修饰胰岛素样生长因子-1 受体。
Angew Chem Int Ed Engl. 2022 Dec 5;61(49):e202211320. doi: 10.1002/anie.202211320. Epub 2022 Nov 9.
5
The emerging complexity of PDGFRs: activation, internalization and signal attenuation.PDGFRs 的新兴复杂性:激活、内化和信号衰减。
Biochem Soc Trans. 2020 Jun 30;48(3):1167-1176. doi: 10.1042/BST20200004.
6
A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluid.一种用于检测脑脊液中周细胞损伤生物标志物的新型敏感检测方法。
Alzheimers Dement. 2020 Jun;16(6):821-830. doi: 10.1002/alz.12061. Epub 2020 Apr 16.
7
Targeting microtubules sensitizes drug resistant lung cancer cells to lysosomal pathway inhibitors.靶向微管可增强耐药肺癌细胞对溶酶体途径抑制剂的敏感性。
Theranostics. 2020 Feb 3;10(6):2727-2743. doi: 10.7150/thno.38729. eCollection 2020.
8
More than the sum of the parts: Toward full-length receptor tyrosine kinase structures.整体大于部分之和:构建全长受体酪氨酸激酶结构。
IUBMB Life. 2019 Jun;71(6):706-720. doi: 10.1002/iub.2060. Epub 2019 May 2.
9
A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy.单克隆抗体癌症治疗的抗血管生成靶点综述
Int J Mol Sci. 2017 Aug 17;18(8):1786. doi: 10.3390/ijms18081786.
10
Distinct cellular properties of oncogenic KIT receptor tyrosine kinase mutants enable alternative courses of cancer cell inhibition.致癌性KIT受体酪氨酸激酶突变体的独特细胞特性使得癌细胞抑制有了替代途径。
Proc Natl Acad Sci U S A. 2016 Aug 16;113(33):E4784-93. doi: 10.1073/pnas.1610179113. Epub 2016 Aug 1.

本文引用的文献

1
Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor.干细胞因子激活受体酪氨酸激酶KIT的结构基础。
Cell. 2007 Jul 27;130(2):323-34. doi: 10.1016/j.cell.2007.05.055.
2
Origin and molecular evolution of receptor tyrosine kinases with immunoglobulin-like domains.具有免疫球蛋白样结构域的受体酪氨酸激酶的起源与分子进化
Mol Biol Evol. 2006 Jun;23(6):1232-41. doi: 10.1093/molbev/msk007. Epub 2006 Mar 21.
3
A structure-based model for ligand binding and dimerization of EGF receptors.一种基于结构的表皮生长因子受体配体结合与二聚化模型。
Proc Natl Acad Sci U S A. 2004 Jan 27;101(4):929-34. doi: 10.1073/pnas.0307285101. Epub 2004 Jan 19.
4
An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors.一目了然的情况?对表皮生长因子/表皮生长因子受体激活的最新见解。
Mol Cell. 2003 Sep;12(3):541-52. doi: 10.1016/s1097-2765(03)00350-2.
5
Assembly of cell regulatory systems through protein interaction domains.通过蛋白质相互作用结构域组装细胞调节系统。
Science. 2003 Apr 18;300(5618):445-52. doi: 10.1126/science.1083653.
6
Cell signaling by receptor tyrosine kinases.受体酪氨酸激酶介导的细胞信号传导
Cell. 2000 Oct 13;103(2):211-25. doi: 10.1016/s0092-8674(00)00114-8.
7
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization.三元成纤维细胞生长因子-成纤维细胞生长因子受体-肝素复合物的晶体结构揭示了肝素在成纤维细胞生长因子受体结合和二聚化中的双重作用。
Mol Cell. 2000 Sep;6(3):743-50. doi: 10.1016/s1097-2765(00)00073-3.
8
Crystal structure of human stem cell factor: implication for stem cell factor receptor dimerization and activation.人干细胞因子的晶体结构:对干细胞因子受体二聚化和激活的启示
Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7732-7. doi: 10.1073/pnas.97.14.7732.
9
Flt3 ligand structure and unexpected commonalities of helical bundles and cystine knots.Flt3配体的结构以及螺旋束和胱氨酸结的意外共性。
Nat Struct Biol. 2000 Jun;7(6):486-91. doi: 10.1038/75896.
10
Structure of the active core of human stem cell factor and analysis of binding to its receptor kit.人干细胞因子活性核心的结构及其与受体kit结合的分析
EMBO J. 2000 Jul 3;19(13):3192-203. doi: 10.1093/emboj/19.13.3192.

血小板衍生生长因子受体胞外域膜近端区域之间的接触是受体激活所必需的,但不是受体二聚化所必需的。

Contacts between membrane proximal regions of the PDGF receptor ectodomain are required for receptor activation but not for receptor dimerization.

作者信息

Yang Yan, Yuzawa Satoru, Schlessinger Joseph

机构信息

Department of Pharmacology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA.

出版信息

Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7681-6. doi: 10.1073/pnas.0802896105. Epub 2008 May 27.

DOI:10.1073/pnas.0802896105
PMID:18505839
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2409387/
Abstract

The mechanism of PDGF-receptor beta (PDGFRbeta) activation was explored by analyzing the properties of mutant receptors designed based on the crystal structure of the extracellular region of the related receptor tyrosine kinase KIT/stem cell factor receptor. Here, we demonstrate that PDGF-induced activation of a PDGFRbeta mutated in Arg-385 or Glu-390 in D4 (the fourth Ig-like domain of the extracellular region) was compromised, resulting in impairment of a variety of PDGF-induced cellular responses. These experiments demonstrate that homotypic D4 interactions probably mediated by salt bridges between Arg-385 and Glu-390 play an important role in activation of PDGFRbeta and all type III receptor tyrosine kinases. We also used a chemical cross-linking agent to covalently cross-link PDGF-stimulated cells to demonstrate that a Glu390Ala mutant of PDGFRbeta undergoes typical PDGF-induced receptor dimerization. However, unlike WT PDGFR that is expressed on the surface of ligand-stimulated cells in an active state, PDGF-induced Glu390Ala dimers are inactive. Although the conserved amino acids that are required for mediating D4 homotypic interactions are crucial for PDGFRbeta activation, these interactions are dispensable for PDGFRbeta dimerization. Moreover, PDGFRbeta dimerization is necessary but not sufficient for tyrosine kinase activation.

摘要

通过分析基于相关受体酪氨酸激酶KIT/干细胞因子受体细胞外区域晶体结构设计的突变受体的特性,探讨了血小板衍生生长因子受体β(PDGFRβ)的激活机制。在此,我们证明,在D4(细胞外区域的第四个免疫球蛋白样结构域)中Arg-385或Glu-390发生突变的PDGFRβ的血小板衍生生长因子(PDGF)诱导激活受到损害,导致多种PDGF诱导的细胞反应受损。这些实验表明,可能由Arg-385和Glu-390之间的盐桥介导的同型D4相互作用在PDGFRβ和所有III型受体酪氨酸激酶的激活中起重要作用。我们还使用化学交联剂将PDGF刺激的细胞共价交联,以证明PDGFRβ的Glu390Ala突变体经历典型的PDGF诱导的受体二聚化。然而,与在配体刺激细胞表面以活性状态表达的野生型(WT)PDGFR不同,PDGF诱导的Glu390Ala二聚体是无活性的。虽然介导D4同型相互作用所需的保守氨基酸对PDGFRβ激活至关重要,但这些相互作用对于PDGFRβ二聚化是可有可无的。此外,PDGFRβ二聚化对于酪氨酸激酶激活是必要的,但不是充分的。